Latest Board Leadership Transition News

Redox Limited posted a strong FY26 with record revenue of $1.33 billion, a 19.2% jump in statutory net profit, and a 4% dividend increase, while announcing a board leadership transition.

ASX Limited reported a 13.3% rise in operating revenue to $1.25 billion for FY26, with underlying net profit up 5.2%, despite a 3.5% dip in statutory profit due to significant one-off costs including a $20.5 million ASIC penalty. The company declared a fully franked final dividend of 104.7 cents per share and appointed Anthony Attia as CEO.

The Calmer Co. International Limited announces a leadership change with James S. Tonkin appointed Chairman as the company accelerates its U.S. market growth in natural kava products.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

IDP Education Limited announces the appointment of Tracey Horton AO as Chair, succeeding Peter Polson after an 18-year tenure. This leadership change marks a key milestone in the company’s ongoing board renewal.

NOVONIX announces the departure of CEO Dr. Chris Burns, with CFO Robert Long stepping in as interim CEO amid plans to scale production at its Riverside facility.